Celldex Therapeutics (CLDX) Asset Utilization Ratio (2011 - 2026)

Celldex Therapeutics' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.0 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 83.96% year-over-year to 0.0 in Q1 2026; TTM through Mar 2026 was 0.0, a 83.96% decrease from a year earlier, with the FY2025 full-year figure at 0.0, down 79.87% from the prior year.
• Asset Utilization Ratio fell to 0.0 in Q1 2026 per CLDX's latest filing, from 0.0 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.02 in Q4 2023 and bottomed at 0.0 in Q1 2026.
• The 5-year median for Asset Utilization Ratio is 0.01 (2024), against an average of 0.01.
• Across the five-year window, Asset Utilization Ratio sank 95.1% in 2022 and jumped 439.49% in 2023, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then soared by 182.66% to 0.02 in 2023, then tumbled by 52.91% to 0.01 in 2024, then plunged by 71.11% to 0.0 in 2025, then slumped by 36.96% to 0.0 in 2026.
• Per Business Quant, the three latest CLDX Asset Utilization Ratio figures stand at 0.0 (Q1 2026), 0.0 (Q4 2025), and 0.0 (Q3 2025).